The Yuan has racked up another huge gain in its advance to become the world’s premier AI platform. The Yuan recently sealed a deal to share its content with New York-based business media giant Dow Jones. The Yuan’s articles now feature in Dow Jones' Factiva business intelligence platform.

The massive Nasdaq screen in New York’s Times Square lit up on October 16 emblazoned with The Yuan’s manifesto to the world demanding free access by all to global medical data and to announce our Open Letter to the leaders of all nations urging global cooperation to permit free access to medical data to serve all humanity, not just a few narrow interests.

The alliance of Big Pharma and Big Tech in the mostly successful quest to develop vaccines to vanquish COVID-19 has been a keynote of the pandemic. In the follow-up on The Yuan platform series of articles predicting the evolution of AI in 2022, The Yuan editor and contributor Ben Armour relates whether his forecast of AI’s development trajectory hit the mark or fell short or wide of it. Original content superseded by events is omitted for the sake of brevity.

The threat of stagflation is increasingly worrisome, with both short-term and long-term structural factors to blame. Can the widespread implementation of AI help to offset some of these factors? And even if it can, will that be enough to avert a worst-case scenario for the global economy?

E-carmaker Tesla CEO Elon Musk has clinched a deal to take over Twitter for US$44 billion in one of the biggest leveraged buyouts every, one likely to shift control of the platform to the world’s richest person. Conservatives hope he restores ex-US President Donald Trump and other de-platformed firebrand right-wing politicos, while liberals hope he will curb fringe speech and conspiracy theorists and stifle disinformation. Dexter Thillien, Lead Analyst, Technology & Telecoms, The Economist Intelligence Unit, talks up the repercussions of this earth-shattering takeover with The Yuan.

China and the United States have officially locked horns in a contest of titans to determine which superpower will emerge as the world’s foremost leader in artificial intelligence. Ben Armour and Jack Kotin, editors and contributors at The Yuan, break down the current situation and predict what the future may hold.

China’s artificial intelligence policy shoots for nothing less than global supremacy by the decade’s end. In this second installment of his two-part essay The Yuan contributor Ben Armour speculates as to whether the country will succeed in its audacious bid to topple the United States and set itself at the top of the AI totem pole or whether this quest will ultimately prove chimerical.

The issuance of China’s most recent key artificial intelligence policy document in November has brought its AI governance and support mechanism to fruition. The Yuan contributor Ben Armour leads a guided tour through the labyrinth of this eight-document suite that lays out Beijing’s bold initiative to overthrow the United States and take over as top dog in the AI domain.

The Yuan contributor Ben Armour concludes his trilogy in this the third portion of his three-part series on amorous artificial intelligence. The first tranche in this sequence homed in on sex robots, while the second discoursed on love+AI in the form of chatbots. For this segment, strap on your virtual reality headset, and brace for blast-off as we zoom through the ether with our favorite billionaires hand-in-hand with AI in quest of life eternal.

The Yuan contributor Ben Armour continues his disquisition in this the second installment of his three-part series on amorous artificial intelligence. The first tranche in this series focused on sex robots. This one addresses love+AI in the incorporeal form of chatbots.

Views on the ‘marriage’ of humans and artificial intelligence are all over the shop, with the issue of sex robots a particular bone of contention. The Yuan contributor Ben Armour threads through this minefield and attempts to answer the question as to whether AI+love is a mésalliance, or a match made in the stars in this three-part series.

The alliance of Big Pharma and Big Tech in the mostly successful quest to develop vaccines to defeat COVID-19 has been one of the most noteworthy events of this year. In the last of the series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022, Ben Armour explores how this marriage has transfigured healthcare, as well as reaping a windfall for both sectors, and forecasts what this union holds in store for 2022.

A pioneering new report offers an overview of pharma RWS/RCT industry developments in 2020-2021, Asia’s RWS market size, trends there and in China - where it predicts 40 percent yearly growth - and showcases Asian RWS industry leaders. It discusses use of virtual Twin Studies, GWAS, Pharmacovigilance and AI, and explores RWS and AI used in diagnostics, biomarkers, image analysis, disease prevention, and Big Data. It then cites the challenges and opportunities faced by AI-driven WRS and lists governmental regulations on RWS and Big Data in Asia.

'Terminator' said, I'll be back," and now indeed returns in this report on the US Defense Intelligence agency's 'Project MARS.' Let Machine Learning (ML) and Neural Network expert Pawel Maksymiak show you the ins and outs of this chilling system, which like Skynet in the movie, deploys the ultimate assassins on AI-targeted kills, among the many other robotic weapons in its arsenal. This story is de rigueur reading for all fans of the film franchise.

All eyes were on AI+Medical at the recent World Artificial Intelligence Conference 2021 in Shanghai, while AI+Healthcare also came under the spotlight at last month’s Arab Health and its intertwined Medlab Middle East in Duba. Differing in theme, the three events still have much in common and highlight the ever-closer marriage of AI and medicine.

‘AI Says Men Are Lazy,’ a headline proclaimed last year. This may be a case of the pot calling the kettle black. AI absorbs the worst traits of its human minders, and indolence is no exception. Slothful AI can be harmful or beneficial in different scenarios. Thus, one AI application took shortcuts in diagnosing COVID-19, with potentially dire consequences. Lazy AI also solved a big problem for the bike-sharing business – the ‘rebalancing problem’ by simply doing nothing.